Speaker illustration

Mr Enrique Ortega Sollero

Madrid (Spain)

Anti-mmu-mir-721 as a therapeutic target for immune checkpoint inhibitor-associated myocarditis

Event: ESC Cardio-Oncology 2025

Topic: Research and New Technology

Session: Young Investigator Award - Basic and Translational Research

Thumbnail